United States · FDA National Drug Code directory
LUMIGAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0023-3205_39a1b7fa-9866-4b23-a97e-5dc3e663ad4a
- Product NDC
- 0023-3205
- Form
- SOLUTION/ DROPS
- Composition / generic term
- bimatoprost
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100910
- Source listing expiry
- 20271231
Source-listed ingredients
- BIMATOPROST — .1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (0023-3205-02) / 2.5 mL in 1 BOTTLE, DROPPER · 0023-3205-02
- 1 BOTTLE, DROPPER in 1 CARTON (0023-3205-03) / 2.5 mL in 1 BOTTLE, DROPPER · 0023-3205-03
- 1 BOTTLE, DROPPER in 1 CARTON (0023-3205-05) / 5 mL in 1 BOTTLE, DROPPER · 0023-3205-05
- 1 BOTTLE, DROPPER in 1 CARTON (0023-3205-08) / 7.5 mL in 1 BOTTLE, DROPPER · 0023-3205-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →